The Archer FusionPlex Solid Tumor Kit is a robust targeted sequencing assay to simultaneously detect and identify fusions and other mutations associated with over 50 genes linked to various carcinomas. Also included in the kit are primers that
target known sarcoma- and hematological malignancy-associated fusions as well as prominent BRAF and PDGFRA mutations. The power of the FusionPlex Solid Tumor Kit lies in Archer’s proprietary Anchored Multiplex PCR-based enrichment (AMPTM).
This chemistry enables detection of all fusions associated with the genes in this kit in a single sequencing assay, even without prior knowledge of fusion partners or breakpoints.